Peapod Bio CEO Zachary Gurard-Levin to present a Webinar November 18, 2025 hosted by Bruker.

Title: The evolution of combining surface chemistry and MALDI mass spectrometry: A powerful foundation for high-throughput screening

When: November 18, 2025 at 11:00 am EDT | 8:00 am PDT | 5:00 pm CEST followed by live Q&A.

In this webinar hosted by Bruker, Gurard-Levin will discuss the development of different surface chemistries and their applications in early drug discovery. He will showcase how innovation at the interface of surface chemistry, MALDI mass spectrometry, and biological assays are enabling new solutions for value-driven high-throughput screening platforms to accelerate drug discovery for even the most challenging targets. Finally, the webinar will highlight how Peapod Bio combines state-of-the-art MALDI instrumentation from Bruker with polymeric enrichment arrays (PEAs) to measure biochemical activities and binding interactions (in an affinity selection mass spectrometry (ASMS) platform) for virtually any target.

Key learning objectives:

• Understand how surface chemistry enhances assay design for small molecule drug discovery
• Explore the advantages of integrating surface chemistries with MALDI mass spectrometry for high-throughput screening
• Recognize the impact on small molecule drug discovery pipelines

Who should attend?

• Researchers interested in new workflows for high-throughput screening
• Scientists interested in high-throughput mass spectrometry
• Investigators working in biochemical and biophysical assay development

Register here to save your spot!